首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2051044

藥物濫用治療市場：按類型、治療方法、年齡層、治療環境和地區分類

Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年藥物濫用治療市場價值為128.8億美元，預計到2033年將達到235.5億美元。預計從2026年到2033年，該市場將以9.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	128.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.00%	2033年市場規模預測：	235.5億美元

藥物濫用治療是指旨在控制藥物成癮、支持長期戒斷和康復的各項計劃和活動。藥物濫用障礙，也稱為成癮，是指儘管有害且具有成癮性的物質會產生負面影響，但仍強迫性或不受控制地使用它們。常見的濫用物質包括酒精、鴉片類藥物、大麻、古柯鹼和甲基安非他命。藥物濫用障礙的主要徵兆包括無法減少攝取量、出現強烈的渴望（例如，在夜店吸毒）以及停止使用後出現戒斷症狀。成癮者通常會出現自控力下降、社交問題、危險使用行為，有時甚至會出現肢體依賴。藥物濫用治療旨在透過治療性介入、諮商、藥物治療和社區支持計畫來解決成癮的生物學、心理學、社會學和行為學方面的問題。全球藥物濫用率的上升正在推動對有效治療方法的需求。

市場動態

全球藥物濫用治療市場成長的主要促進因素包括藥物濫用障礙盛行率的上升、人們對獲得治療途徑的認知不斷提高、有利的法規和政策，以及新型輔助性治療產品的上市。然而，與成癮相關的社會污名、低收入地區治療設施的匱乏以及治療方案依從性問題可能會抑制市場成長。數位化治療解決方案、綜合護理模式、針對特定成癮的標靶治療的開發以及向新興市場的拓展，為市場相關人員提供了巨大的成長機會。從區域來看，北美憑藉其先進的醫療保健基礎設施和較高的公眾意識，在市場中佔據主導地位。然而，預計亞太地區在預測期內將展現出良好的成長前景。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球藥物濫用治療市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球藥物濫用治療市場報告》旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球藥物濫用治療市場中使用的各種策略矩陣，更輕鬆地做出決策。

市場動態
- 促進因素：
  - 毒品和酒精消費量增加
  - 擴大政府和非政府組織的支持
- 抑制因子
  - 與藥物成癮相關的社會偏見
  - 合適的復健設施短缺
- 機會
  - 開發中國家的未開發市場
  - 企業市場占有率分析
主要亮點
市場趨勢
PEST分析
波特的分析
近期產品核可上市
併購和合作

第4章全球藥物濫用治療市場：按類型分類，2021-2033年

酒精
鴉片類藥物（例如海洛因、處方止痛藥）
煙草/尼古丁
古柯鹼
大麻
甲基安非他命
其他非法藥物（例如苯二氮平類藥物）

第5章全球藥物濫用治療市場：依治療類型分類，2021-2033年

鴉片類藥物
尼古丁
酒精
菸草
其他藥物（托吡酯、Modafinil非尼等）

第6章全球藥物濫用治療市場：依年齡層別分類，2021-2033年

青春期
成人
老年人

第7章全球藥物濫用治療市場：依治療環境分類，2021-2033年

門診治療
住院治療
居住治療設施
戒毒中心

第8章全球藥物濫用治療市場：依地區分類，2021-2033年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Indivior PLC
- Pfizer, Inc.
- Johnson & Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd.
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players
分析師意見

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6671

Substance Abuse Treatment Market is estimated to be valued at USD 12.88 Bn in 2026 and is expected to reach USD 23.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 12.88 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 23.55 Bn

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Market Segmentation

Global Substance Abuse Treatment Market, By Type (Revenue, USD Bn, 2021 - 2033)
Alcohol
Opioids (e.g., heroin, prescription painkillers)
Tobacco/nicotine
Cocaine
Marijuana
Methamphetamines
Other illicit drugs (Benzodiazepines, etc.)
Global Substance Abuse Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
Opioid
- Methadone
- Buprenorphine
- Extended-release naltrexone
- Lofexidine
Nicotine
- Nicotine replacement therapies (available as a patch, inhaler, or gum)
- Bupropion
- Varenicline
Alcohol
- Naltrexone
- Disulfiram
- Acamprosate
Tobacco
- Clonidine
- Nortriptyline
Others (Topiramate, Modafinil, etc.)
Global Substance Abuse Treatment Market, By Age Group (Revenue, USD Bn, 2021 - 2033)
Adolescents
Adults
Geriatric
Global Substance Abuse Treatment Market, By Treatment Setting (Revenue, USD Bn, 2021 - 2033)
Outpatient Treatment
- Outpatient Clinics
- Private Practices
Inpatient Treatment
- Rehabilitation Centers
- Hospitals
Residential Treatment Facilities
Detoxification Centers
Global Substance Abuse Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies
Indivior PLC
Pfizer, Inc.
Johnson & Johnson Inc.
Mallinckrodt Pharmaceuticals
Teva Pharmaceuticals, Inc.
Par Pharmaceutical, Inc.
USWM, LLC
Valeant Pharmaceuticals
Greenyard Pharmaceutical Ltd.
Cipla Health Limited
Perrigo
Haleon Group of Companies
Ventus Medical
Glenmark
Other Prominent Players

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment Type
- Market Snippet, By Age Group
- Market Snippet, By Treatment Setting
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers:
  - Increasing consumption of drugs and alcohol
  - Growing support from government and NGOs
- Restraints
  - Social stigma associated with substance dependence
  - Lack of adequate rehabilitation facilities
- Opportunities
  - Untapped markets in developing countries
  - Company Market Share Analysis
Key Highlights
Market Trends
PEST Analysis
PORTER's Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Opioids (e.g., heroin, prescription painkillers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Tobacco/nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Cocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Marijuana
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Methamphetamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Other illicit drugs (Benzodiazepines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Substance Abuse Treatment Market, By Treatment Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Opioid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Methadone
  - Buprenorphine
  - Extended-release naltrexone
  - Lofexidine
Nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Nicotine replacement therapies (available as a patch, inhaler, or gum)
  - Bupropion
  - Varenicline
Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Naltrexone
  - Disulfiram
  - Acamprosate
Tobacco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Clonidine
  - Nortriptyline
Others (Topiramate, Modafinil, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Substance Abuse Treatment Market, By Age Group, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

7. Global Substance Abuse Treatment Market, By Treatment Setting, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Outpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Outpatient Clinics
  - Private Practices
Inpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Rehabilitation Centers
  - Hospitals
Residential Treatment Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Detoxification Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

8. Global Substance Abuse Treatment Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- Indivior PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Johnson & Johnson Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Par Pharmaceutical, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- USWM, LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Valeant Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Greenyard Pharmaceutical Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cipla Health Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Perrigo
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Haleon Group of Companies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ventus Medical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Glenmark
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Other Prominent Players
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

藥物濫用治療市場：按治療形式、藥物類型、服務提供者、支付方式和最終用戶分類－2026-2032年全球市場預測

全球藥物濫用治療市場：依治療類型、應用及地區分類的分析－市場規模、產業趨勢、機會分析及2026-2035年預測

全球藥物濫用治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

藥物濫用治療市場－2026-2031年預測

FAQ

藥物濫用治療市場：按類型、治療方法、年齡層、治療環境和地區分類